Rc. Hendel et al., Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging, CIRCULATION, 99(21), 1999, pp. 2742-2749
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Soft tissue attenuation is a prominent cause of single-photon em
ission computed tomography (SPECT) imaging artifacts, which may result in r
educed diagnostic accuracy of myocardial perfusion imaging. A method incorp
orating simultaneously acquired transmission data permits nonuniform attenu
ation correction and when incorporating scatter correction and resolution c
ompensation may substantially reduce interpretive errors,
Methods and Results-A prospective multicenter trial was performed recruitin
g patients with angiographically documented coronary disease (n = 96) and g
roup of subjects with a low likelihood of disease (n = 88). The uncorrected
and attenuation/scatter corrected images were read independently, without
knowledge of the patient's clinical data. The detection of greater than or
equal to 50% stenosis was similar using uncorrected perfusion data or with
attenuation/scatter correction and resolution compensation (visual or visua
l plus quantitative analysis), 76% versus 75% versus 78%, respectively (P=N
S). The normalcy rate, however, was significantly improved with this new me
thodology, using either the corrected images (86% vs 96%; P=0.011) or with
the corrected data and quantitative analysis (86% vs 97%; P=0.007). The rec
eiver operator characteristic curves were also found to be marginally but n
ot significantly higher with attenuation/scatter correction than with tradi
tion SPECT imaging. However, the ability to detect multivessel disease was
reduced with attenuation/scatter correction, Regional differences were also
noted, with reduced sensitivity but improved specificity for right coronar
y lesions using attenuation/scatter correction methodology.
Conclusions-This multicenter trial demonstrates the initial clinical result
s of a new SPECT perfusion imaging modality incorporating attenuation and s
catter correction in conjunction with Tc-99m sestamibi perfusion imaging, S
ignificant improvements in the normalcy rate were noted without a decline i
n overall sensitivity but with a reduction in detection of extensive corona
ry disease.